Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Sun Yat-sen University
Duke University
ChineseAMS
Duke University
Fred Hutchinson Cancer Center
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
GlaxoSmithKline